4EC-58585-96067
3 vaccinations
2 coded responses
26 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 483 / MI
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 1 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Survey response — days 1–6 daily, dose 1MedDRA: Visual impairment — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workFree text: Seeing spots, blind spotsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
-
2021-04-16
Dose 2 — Pfizer-BioNTech
-
2021-04-16
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-22
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-16
- 2021-05-21
- 2021-05-28
-
2021-07-16
Survey response — 3 months, dose 2MedDRA: Taste disorder — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Altered tasteMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-20
- 2021-10-15
-
2021-10-29
Dose 3 — Pfizer-BioNTech
- 2022-04-18
- 2022-04-29
- 2022-10-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech | |
| 3 | 2021-10-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-16 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Seeing spots, blind spots
Release 9 — 3 months, dose 2
Symptoms: Altered taste
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Taste disorder | ✓ | · | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release